NeoGenomics Forecasts FY23 Revenues Of $545M-$555M Vs. $535.08M Estimate
NeoGenomics expects FY23 Adjusted EBITDA loss of $(27)M-$(22)M.
Option Care Health Expects FY23 Net Revenue Of $4.15B-$4.375B Vs. $4.29B Estimate
Adjusted EBITDA of $370 million to $390 million
Cash flow from operations of at least $240 million
Genuine Parts Company Fy23 Outlook: Adj. EPS $8.80 – $8.95 Vs. $8.67 Estimate, GAAP EPS $8.80 – $8.95, Revenue Growth 4% – 6%, FCF $800M – $1B
2023 Outlook
In consideration of several factors, the company is establishing full-year 2023 guidance. The company considered its recent business trends and financial results, current growth plans, strategic
Teleflex Expects FY23 Adjusted EPS Of $13.00-$13.60 Vs. $13.49 Estimate
GAAP revenue growth guidance of 4.25% to 5.75%.
Constant currency revenue growth guidance of 4.75% to 6.25%
Enovis FY23 Outlook: EPS $2.15 – $2.30 Vs. $2.43 Estimate, Revenue Growth 5% – 6%
2023 Financial Outlook
Enovis also announced financial expectations for 2023. Revenue is expected to organically grow 5-6% from the prior year, with adjusted EBITDA of $255 to $265 million and adjusted earnings per
PG&E FY23 GAAP EPS Outlook $0.98 – $1.13, Non-GAAP EPS Outlook $1.19 – $1.23 Vs. $1.22 Estimate
PG&E Corporation's 2023 Earnings Guidance
2023
EPS Guidance
Low
High
Estimated
Bath & Body Works FY23 Outlook: EPS $2.50 – $3.00 Vs. $3.64 Estimate, Revenue Decline To Mid-Single Digits
2023 Outlook
The company's forecast takes into consideration ongoing macroeconomic uncertainty and assumes a continuation of fourth quarter 2022 sales trends for the first half of fiscal 2023.
The company expects
Bath & Body Works Q1 Outlook: EPS $0.17 – $0.27 Vs. $0.44 Estimate, Revenue Decline Low To Mid-Single Digits
2023 Outlook
The company's forecast takes into consideration ongoing macroeconomic uncertainty and assumes a continuation of fourth quarter 2022 sales trends for the first half of fiscal 2023.
The company expects
U.S. Physical Therapy Expects The Company’s Adjusted EBITDA For 2023 To Be In The Range Of $75M-$80M
Management Provides 2023 Earnings Guidance
Management currently expects the Company's Adjusted EBITDA for 2023 to be in the range of $75.0 million to $80.0 million. The range considers that the
SJW Group Sees FY23 EPS $2.40-$2.50 Vs $2.49 Est
2023 Earnings Guidance
Guidance for 2023 is based on constructive outcomes in the SJWC Cost of Capital proceeding in California currently in progress, a GRC in Maine's Biddeford-Saco Division scheduled to